Bristol Myers Squibb submitted an FDA application for mezigdomide with carfilzomib and dexamethasone in relapsed multiple myeloma. The FDA accepted the New Drug Application and set a PDUFA action date ...

Stellantis (NYSE:STLA) reported 1.6 million estimated consolidated vehicle shipments for the second quarter of 2026, a 10% year-over-year increase. North American performance led the growth with a 38% ...

Data I/O signed a non-binding agreement to acquire embedded software security assets from IAR. Financial terms were not disclosed, while Data I/O shares closed at $1.86 after the announcement. Data ...

InMode (NASDAQ:INMD) confirmed its Board of Directors received an unsolicited $16.75 per share acquisition proposal from Steel Partners Holdings. An independent Special Committee of the Board, ...

The Brazilian government has extended its 12% temporary crude oil export tax for an additional 60 days. Karoon Energy shares fell to $1.40 following the extension of the temporary export levy. The ...

Japanese financial company CRYL has launched a Bitcoin-backed lending service offering loans of between 1 million yen (US$6,200) and 1 billion yen (US$6.2 million) to individuals and businesses ...

Chevron signed an agreement to sell 46 petajoules of natural gas to Western Australia's largest gas retailer, Alinta Energy. The five-year supply deal is scheduled to commence in July 2027 from three ...

Global wind supplier Vestas purchased the 272-megawatt St Patricks Plains wind project from Ark Energy. Following the transaction, the Vestas share price closed up at 180.30 Danish krone on the ...

The co-founders of Chemist Warehouse may sell up to 20% of their combined shareholding. Sigma Healthcare shares rose 2.5% to close at $2.87 following the market announcement. The potential sale ...

Marex Group signed a definitive agreement to acquire Singapore-based Bright Point International (BPI). The transaction will add approximately $800 million in client balances and more than 70 regional ...

The French antitrust regulator confirmed its ongoing investigation into Nvidia is winding down. The agency has been investigating the graphics giant over alleged anti-competitive market practices. The ...

The CARDIO-TTRansform trial did not reach its primary endpoint for treating transthyretin-mediated amyloid cardiomyopathy. Adding eplontersen to the modern standard of care yielded no statistically ...